INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

ETRAElectra Therapeutics, Inc.

CIK 0002088082

EDGAR filingsOpen in network
Disclosed transactions8
Buys / sells0 / 0
Max Insider Score9
Connections5with evidence

ETRA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
PG
Parry GrahamChief Scientific Officer
ETRAElectra Therapeutics, Inc.
Derivative conversion
C—
85.5K sh
Sep 21, 2026Sep 21, 2026
traded Sep 21, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Parry GrahamChief Scientific Officer · Sep 21, 2026
  • ← Insider ofevidence
    Koe Gary S.Chief Technical Officer · Sep 21, 2026
  • ← Insider ofevidence
    Dong Quehuong (Kathy)Director, President & CEO · Sep 21, 2026
9
KS
Koe Gary S.Chief Technical Officer
ETRAElectra Therapeutics, Inc.
Derivative conversion
C
—
63.7K sh
Sep 21, 2026
Sep 21, 2026
traded Sep 21, 2026
+0d
SEC FORM 4

Evidence

9
DK
Dong Quehuong (Kathy)Director, President & CEO
ETRAElectra Therapeutics, Inc.
Derivative conversion
C—
455.5K sh
Sep 21, 2026Sep 21, 2026
traded Sep 21, 2026
+0dSEC FORM 4

Evidence

9
SN
Stagliano NancyDirector
ETRAElectra Therapeutics, Inc.
Derivative conversion
C—
255.6K sh
Sep 21, 2026Sep 21, 2026
traded Sep 21, 2026
+0dSEC FORM 4

Evidence

9
PG
Parry GrahamChief Scientific Officer
ETRAElectra Therapeutics, Inc.
Derivative conversion
C—
85.5K sh
Sep 21, 2026Sep 21, 2026
traded Sep 21, 2026
+0dSEC FORM 4

Evidence

9
SN
Stagliano NancyDirector
ETRAElectra Therapeutics, Inc.
Derivative conversion
C—
255.6K sh
Sep 21, 2026Sep 21, 2026
traded Sep 21, 2026
+0dSEC FORM 4

Evidence

9
KS
Koe Gary S.Chief Technical Officer
ETRAElectra Therapeutics, Inc.
Derivative conversion
C—
63.7K sh
Sep 21, 2026Sep 21, 2026
traded Sep 21, 2026
+0dSEC FORM 4

Evidence

9
DK
Dong Quehuong (Kathy)Director, President & CEO
ETRAElectra Therapeutics, Inc.
Derivative conversion
C—
455.5K sh
Sep 21, 2026Sep 21, 2026
traded Sep 21, 2026
+0dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Stagliano NancyDirector · Sep 21, 2026